KALV icon

KalVista Pharmaceuticals

73 hedge funds and large institutions have $244M invested in KalVista Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 28 increasing their positions, 14 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
73
Holders Change
-3
Holders Change %
-3.95%
% of All Funds
1.44%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.1%
New
19
Increased
28
Reduced
14
Closed
17
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
Neuberger Berman Group
76
Neuberger Berman Group
New York
-$682K -58,812 Closed
SSA
77
Schonfeld Strategic Advisors
New York
-$471K -40,600 Closed
SCM
78
Stonepine Capital Management
Oregon
-$383K -33,033 Closed
Renaissance Technologies
79
Renaissance Technologies
New York
-$221K -19,028 Closed
Swiss National Bank
80
Swiss National Bank
Switzerland
-$204K -17,600 Closed
TI
81
Trexquant Investment
Connecticut
-$183K -15,799 Closed
ECM
82
ExodusPoint Capital Management
New York
-$158K -13,600 Closed
VEA
83
Virtus ETF Advisers
New York
-$147K -12,688 Closed
Invesco
84
Invesco
Georgia
-$130K -11,257 Closed
JG
85
Jefferies Group
New York
-$131K -11,250 Closed
Citadel Advisors
86
Citadel Advisors
Florida
-$118K -10,194 Closed
TRCT
87
Tower Research Capital (TRC)
New York
-$45K -3,877 Closed
LC
88
Lindbrook Capital
California
-$15K -1,250 Closed
CSS
89
Cubist Systematic Strategies
Connecticut
-$9K -782 Closed
PHK
90
Point72 Hong Kong
Hong Kong
-$2K -142 Closed